10th annual Adaptive Designs in Clinical Trials London, England, UK 9-10 April 2018

Description:
This year’s agenda has been curated to provide you with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development.

Giving you a fresh take on this vital area of biopharma, the event will ride the wave of technology within the pharmaceutical industry, as we consider how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies.

Featured Speakers include:
James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca
Alex Sverdlov, Director, Statistical Scientist, Novartis
Frank Fleisher, Principal Methodology Statistician, Boehringer-Ingelheim
Christine Fletcher, Executive Director Biostatistics, Amgen
Chris Harbron, Principal Statistical Scientist, Roche
Olivier Collignon, Biostatistician, European Medicines Agency
Beatrice Panico, Medical Advisor, MHRA
Corine Baayen, Senior Biostatistician, H.Lundbeck

URL:
Booking: https://go.evvnt.com/171029-0

Prices:
Book by 15 Dec: GBP 1099,
Book by 31 Jan: GBP 1299,
Book by 28 Feb: GBP 1399,
Standard: GBP 1499.

Time: 8:30 am to 5:30 pm.